Back to Results
First PageMeta Content
Pharmacology / Non-steroidal anti-inflammatory drugs / Merck / Rofecoxib / Sulfones / The New England Journal of Medicine / Naproxen / Pharmaceutical industry / Food and Drug Administration / Medicine / COX-2 inhibitors / Chemistry


Document Date: 2009-11-23 07:26:40

Open Document

File Size: 44,86 KB

Share Result on Facebook

City

Seattle / Boston / New York / London / /

Company

Bombardier / Wall Street Journal / The New England Journal / Oxford University Press / Merck / New York Times / Cox / BMJ Publishing Group / /

Currency

USD / /

/

Event

Product Recall / Employment Change / Product Issues / Person Communication and Meetings / /

Facility

Public Library of Science / /

IndustryTerm

pharmaceutical / public relations / /

MedicalCondition

rheumatoid arthritis / colorectal adenoma / myocardial infarction / /

MedicalTreatment

chemoprevention / Drug therapy / /

Organization

ROYAL SOCIETY OF MEDICINE Volume / ROYAL SOCIETY OF MEDICINE / Food and Drug Administration / Oxford University / Massachusetts Medical Society / /

Person

Franz Ingelfinger / Henry James / Jerry Kassirer / Curfman / Bud Relman / Marcia Angel / Jeff Drazen / Richard Smith / /

/

Position

editor / chief executive / pharmacist / public relations specialist / member of the board / NEJM editor / executive editor / executive editor of the journal / /

Product

Armstrong D. Bitter / naproxen / Vioxx / drug / /

PublishedMedium

the Wall Street Journal / the Public Library of Science / New York Times / the New England Journal of Medicine / the New England Journal / Wall Street Journal / /

RadioProgram

Seattle / /

Technology

http / /

URL

http /

SocialTag